Plaintiffs' Firms From Zyprexa Case Seek More Fees

Law360, New York (October 18, 2007, 12:00 AM EDT) -- Two years after a $690 million settlement was reached in the multidistrict product liability suit over Eli Lilly & Co.’s blockbuster drug Zyprexa, four law firms that represented the plaintiffs have petitioned the district court for $4.2 million more in fees and expenses.

In a motion filed Wednesday in the U.S. District Court for the Eastern District of New York, the Zyprexa plaintiffs’ steering committee I claimed Milberg Weiss LLP, Burg Simpson Eldredge Hersh & Jardine PC, Douglas & London and Seeger Weiss LLP should be...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.